Alspaugh Jonathan Insider Trades

Insider Trading History

Track insider trading activity for Alspaugh Jonathan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
President And CFO
Holding Value $1.45B 19,787,969 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$73.52
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
President And CFO
Holding Value $238M 19,787,969 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$226M 19,787,969 shares
$11.40
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $47.1M 640,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$73.52
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $7.69M 640,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.04M 640,000 shares
$11.00
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $1.56M 130,000 shares
Last Trade
Aug 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.21M 130,000 shares
$17.00
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $9.56M 130,000 shares
Last Trade
Aug 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$73.52
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $1.99M 165,372 shares
Last Trade
Mar 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.73M 75,000 shares
$49.75
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $12.2M 165,372 shares
Last Trade
Mar 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$73.52
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $2.04M 170,000 shares
Last Trade
Feb 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.5M 170,000 shares
$79.25
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $1.09M 90,372 shares
Last Trade
Dec 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.53M 50,000 shares
$90.50
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $485k 40,372 shares
Last Trade
Aug 18, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.23M 7,200 shares
$171.25
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $398k 33,172 shares
Last Trade
Aug 17, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.81M 23,392 shares
$163.00
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $117k 9,780 shares
Last Trade
Aug 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.57M 9,780 shares
$161.00
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $1.92M 160,000 shares
Last Trade
Jul 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.1M 160,000 shares
$175.75
$12.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up